Medindia

X

Compact LeadCare Plus Blood Lead Testing System Produces Results in 3 Minutes

by Julia Samuel on  July 22, 2015 at 11:24 AM Medical Gadgets   - G J E 4
Magellan Diagnostics, Inc., receives US Food and Drug Administration (FDA) clearance to market the LeadCare Plus Blood Lead Testing System in the US for the quantification of lead levels in blood.
Compact LeadCare Plus Blood Lead Testing System Produces Results in 3 Minutes
Compact LeadCare Plus Blood Lead Testing System Produces Results in 3 Minutes
Advertisement

The device neatly fits into even the smallest clinical labs, taking up only 60 square inches (390 sq cm) of desktop space. It relies on single-use consumables and features electronic calibration for quick and easy setup and testing when a suspected patient shows up.

Advertisement
The device can test either capillary or venous whole blood, detecting concentrations of lead down to 1.9 µg/dL. Results are produced within about three minutes and the device can process up to about 20 samples per hour.

Blood lead testing is a critical preventative service for children: the symptoms of lead exposure are non-specific and sub-clinical; therefore a routine blood test is often the only way to identify exposure in a child.

Without early detection, elevated blood lead levels can impair cognition, reduce IQ, and cause attention-deficit disorders. According to the Centers for Disease Control and Prevention (CDC), there are over half a million US children still affected with elevated blood lead levels.

Amy Winslow, president of Magellan Diagnostics, said, "We are pleased that the FDA has cleared the LeadCare Plus System. Our mission is to help expand access to blood lead testing by offering a solution for every setting. With our other products, CLIA-waived LeadCare II for point-of-care testing and LeadCare Ultra for high throughput lab analysis, LeadCare Plus completes this offering by providing a low capital cost system that gives even small labs the opportunity to bring this test in-house."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All